The Education Committee of the Global Specialty Lens Symposium (GSLS) invites the submission of abstracts for the presentation of Free Papers and Posters to be held January 18-21, 2023 at the Horseshoe Las Vegas, formerly Bally’s. The committee seeks topics including new and innovative concepts, clinical cases and research on all aspects of contact lenses (such as materials, designs, lens care, etc.) in addition to related topics such as corneal and ocular surface disease, diagnosis and treatment approaches, and practice management.
Printer Friendly Guidelines
Abstract submissions for the 2023 Global Specialty Lens Symposium (GSLS) will be accepted only through the official GSLS website, www.GSLSymposium.com, until October 3, 2022, at 5:00 p.m. Eastern Standard Time (EST).
There are three categories of abstract submission types: clinical case reports (resident and non-resident) and research.
For clinical case reports abstracts (non-resident first author), please use the following standard headings to structure the abstract: AUTHORS, AFFILIATIONS, TITLE, BACKGROUND, CASE DESCRIPTION, CONCLUSIONS. These case reports require at least 90 days of follow-up care be demonstrated beyond the initial clinical interaction. If it is not evident that 90 days of follow-up care have been provided, the abstract will be rejected.
For clinical case reports abstracts (resident first author), please use the following standard headings to structure the abstract: AUTHORS, AFFILIATIONS, TITLE, BACKGROUND, CASE DESCRIPTION, CONCLUSIONS. These case reports require at least 30 days of follow-up care be demonstrated beyond the initial clinical interaction. If it is not evident that 30 days of follow-up care have been provided, the abstract will be rejected.
For research abstracts, please use the following set of standard headings to structure the abstract: AUTHORS, AFFILIATIONS, TITLE, PURPOSE, METHODS, RESULTS, and CONCLUSIONS.
The abstract, excluding author names and affiliations (i.e., institutions, contact information), is limited to a total of 2,500 characters (including spaces, punctuation, etc). Submissions that exceed this limit will not be accepted by the website, but the submitter will immediately be given the opportunity to modify the submission so that it fits within this size limit. Images and figures within abstracts are not allowed.
The first author will receive immediate confirmation that his or her abstract was received via an e-mail confirmation sent to the address listed for the communicating author.
For research submissions, the first author is asked to indicate his or her preference for a Free Paper or Poster presentation (note that there are a VERY LIMITED number Free Papers). In addition, please indicate in the respective field on the submission form whether you would be willing to consider future publication in Contact Lens Spectrum. The submitting author is also required to assure that the abstract complies with each of the following standards, insofar as they are applicable:
Any and all research involving human subjects must be conducted in accordance with the guidelines provided by the Declaration of Helsinki and in adherence of applicable national and local human subject’s requirements, including an indication of human subject informed consent, as published by The Association for Research in Vision and Ophthalmology.1
Submissions that are clinical trials must indicate that they comply with and have registered on clinicaltrials.gov or regional equivalent.2
Research involving animal subjects must be conducted in accordance with international standards for animal treatment and care, as published by the Association for Research in Vision and Ophthalmology.3
Any and all co-author(s) must read the final, submitted version of the abstract and explicitly consent to include their name(s) in the list of authors. The submitting author is responsible for assuring that all co-authors have had the opportunity review and approve the materials, and for assuring that the work is original and not the work of others.
Potential and actual conflicts of interest must be disclosed as instructed on the abstract submission form per that of GSLS.
All abstracts and posters/presentations must be conducted per current ARBO COPE CE guidelines including the absence of advertising or promoting products, services, instruments or devices. They can be detailed as part of something being used in the research or clinical case, but not feature the commercial product or logos beyond this. Do not include commercial product names in abstract titles as the abstract will be rejected.
Poster presenters are responsible for developing, printing, shipping/transporting, and hanging their poster and will be supplied an appropriately sized board for poster hanging.
First authors must be registered for the Global Specialty Lens Symposium and are expected to present their accepted work; exceptions will not be made for substitute presenters. First authors for selected free papers will receive $150 off registration for the meeting, and poster submissions that are selected will be given $100 off their GSLS registration.
The first author will be notified of the Committee’s decision within 30 days of the submission window’s closure. There will be a poster competition within the three submission categories— Clinical Case Report (non-resident), Clinical Case Report (residents), and Research. The winners will be notified at the GSLS meeting and will receive an American Express gift card. For each submission category, the 1st, 2nd, and 3rd place winners will receive $300 USD, $200 USD, and $100 USD, respectively.
Make sure you download our GSLS app! Attendees can use this app onsite to create a personal agenda, map out visits to their favorite exhibitors, provide feedback, interact with speakers and sessions, and more! You can download the app on the Google Play Store or App Store by searching "PentaVision Conferences.”